Liječnički vjesnik, Vol. 141 No. 11-12, 2019.
Original scientific paper
https://doi.org/10.26800/LV-141-11-12-45
Tomosynthesis guided core biopsy of breast lesions – method review and our results
Kristina Samaržija
; Odjel za radiologiju, Opća bolnica Karlovac
Ines Kolar
; Odjel za radiologiju, Opća bolnica Karlovac
Zoran Jurjević
; Odjel za radiologiju, Opća bolnica Karlovac
Abstract
Percutaneous breast core biopsy is a minimally invasive method which allows preoperative histologic diagnosis of breast lesions. If the lesions are nonpalpable, it is performed under imaging guidance. Some
lesions detected with digital breast tomosynthesis are occult in 2D mammography and cannot be biopsied in conventional stereotactic mode. Therefore, in 2013 tomosynthesis guided breast biopsy was introduced into clinical practice. It uses tomosynthesis views to define the depth of the lesion, without additional projections and triangulation. The procedure is performed with fewer x-ray exposures and therefore with a lower total radiation dose and overall procedure time comparing with stereotactic biopsy. This method has been used in General Hospital
Karlovac since 2015, and during this time 179 procedures were done. Targeting and sampling of the lesions were successful in all cases, as confirmed by the postprocedural tomosynthesis or specimen radiograph for lesions with calcifications. Of the 179 lesions, the histologic diagnoses were malignant in 44 (24.6%) cases, lesions of uncertain malignant potential have been found in 13 (7.3%) cases and benign lesion in 122 (68.2%) cases. Among malignant lesions there were 32 (72.7%) ductal carcinomas in situ (DCIS) and 12 (27.3%) invasive carcinomas. Compared with final diagnosis at surgery, the underestimation rate was 14.3% for DCIS and 25% for lesions of uncertain malignant potential. Benign lesions were followed-up for 24 months. In the sample with the completed period of monitoring, the rate of false negative findings was 2.8%, sensitivity of the method was
86.4%, specificity 100%, positive predictive value 100%, negative predictive value 70%, and accuracy 89.7%. There were no major complications during and after the biopsies. Tomosynthesis guided breast biopsy is not limited only to lesions visible exclusively by this method, but can be used to guide biopsies in patients with lesions
visible also in 2D mammography.
Keywords
BREAST NEOPLASMS – diagnostic imaging, pathology; BREAST DISEASES – diagnostic imaging, pathology; BREAST – pathology; BIOPSY, LARGE-CORE NEEDLE – instrumentation, methods; MAMMOGRAPHY – methods; STEREOTAXIC TECHNIQUES; IMAGING,THREE-DIMENSIONAL; SENSITIVITY AND SPECIFICITY
Hrčak ID:
232893
URI
Publication date:
31.1.2020.
Visits: 6.020 *